Arax Advisory Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Arax Advisory Partners's ADPT Position: Q2 2026 in Review
Arax Advisory Partners increased its Adaptive Biotechnologies (ADPT) stake by 2,668% in Q2 2026, buying an estimated $61.7K and bringing the position to 4,179 shares worth $89.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2820.
Arax Advisory Partners first reported a position in ADPT in Q2 2024 and has held it in 6 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Arax Advisory Partners held 4,179 shares of Adaptive Biotechnologies worth $89.6K as of Q2 2026.
- Arax Advisory Partners bought 4,028 Adaptive Biotechnologies shares in Q2 2026, an estimated $61.7K.
- Adaptive Biotechnologies made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2820 holding.
- Arax Advisory Partners first reported a position in Adaptive Biotechnologies in Q2 2024 and has held it in 6 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.